Comments on: Exhale: Lilly Bails On Alkermes Insulin Inhaler http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/ News, Comment and Conversation Fri, 10 Feb 2012 20:47:25 +0000 http://wordpress.org/?v=2.6.2 By: Chad Shanks, RN http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196423 Chad Shanks, RN Sat, 08 Mar 2008 02:11:17 +0000 http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196423 When I first heard of an insulin inhaler, I thought it was a novel idea. I have family members with insulin-dependant diabetes; two of whom have been on insulin since early childhood. For kids in particular, the insulin inhaler might have proven to be very beneficial. When I first heard of an insulin inhaler, I thought it was a novel idea. I have family members with insulin-dependant diabetes; two of whom have been on insulin since early childhood. For kids in particular, the insulin inhaler might have proven to be very beneficial.

]]> By: Scott http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196383 Scott Sat, 08 Mar 2008 01:37:30 +0000 http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196383 After the billions of dollars big pharma have wasted on this "me-too" product (one which no one wanted to pay for, and served no clinical need that wasn't already being served), perhaps all of these companies will start to develop a form of insulin which is very badly needed ... one which cannot cause hypoglycemia. So far, however, only Beverly, Massachusetts nanotech startup SmartCells has made any real progress on this, leaving Novo, Lilly and Sanofi Aventis scratching their heads as to what went wrong. After the billions of dollars big pharma have wasted on this “me-too” product (one which no one wanted to pay for, and served no clinical need that wasn’t already being served), perhaps all of these companies will start to develop a form of insulin which is very badly needed … one which cannot cause hypoglycemia. So far, however, only Beverly, Massachusetts nanotech startup SmartCells has made any real progress on this, leaving Novo, Lilly and Sanofi Aventis scratching their heads as to what went wrong.

]]> By: Ed Silverman http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196035 Ed Silverman Fri, 07 Mar 2008 20:50:28 +0000 http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-196035 Hi AV, Well, honestly, I wasn't aiming for funny. I think 'exhale' still seems an apt way to sum things up, given that we have a new development involving yet another drugmaker. And the only other mention that could be read as a pun was the phrase about resemblance to a bong, but that simply reiterates what was a valid criticism all along. Nonetheless, I'll keep my joke book and thesaurus handy for the next marketing disaster. Cheers ed Hi AV,

Well, honestly, I wasn’t aiming for funny. I think ‘exhale’ still seems an apt way to sum things up, given that we have a new development involving yet another drugmaker. And the only other mention that could be read as a pun was the phrase about resemblance to a bong, but that simply reiterates what was a valid criticism all along.

Nonetheless, I’ll keep my joke book and thesaurus handy for the next marketing disaster.

Cheers
ed

]]> By: AV Block http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-195994 AV Block Fri, 07 Mar 2008 20:23:58 +0000 http://www.pharmalot.com/2008/03/exhale-lilly-bails-on-alkermes-insulin-inhaler/#comment-195994 Sorry to mention this, but the puns on Exubera and inhaled insulin were funnier back in October. Sorry to mention this, but the puns on Exubera and inhaled insulin were funnier back in October.

]]>